Two studies published in the New England Journal of Medicine compare ablation to antiarrhythmic drugs early in the course of atrial fibrillation (AF). Their "positive" results scare me; AF ablation is ...
Using cryoablation as first-line therapy in patients with newly diagnosed, paroxysmal atrial fibrillation can significantly reduce the risk of recurrence measured by continuous arrhythmia monitoring ...
The EAST—AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention) trial investigated whether rhythm control therapy—with antiarrhythmic drugs or atrial fibrillation ablation—delivered ...
Genetic testing may be considered in patients with early-onset atrial fibrillation (AF), particularly those with a positive family history and lack of conventional clinical risk factors, because ...
A sub-study analysis of the EAST—AFNET 4 trial revealed how genetic risk for atrial fibrillation (AF) and stroke interacts with early rhythm control therapy: Early rhythm control reduces ...
BARCELONA, SPAIN—For patients with paroxysmal and persistent atrial fibrillation (AF), delaying catheter ablation for 12 months while optimizing antiarrhythmic drug therapy has no impact on arrhythmia ...
Sophia Antipolis, 27 March 2023: Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared ...
Late-onset atrial fibrillation affects survival and risk for major adverse cardiovascular events in patients with myocardial infarction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results